VAPAWAY.EU - Research and education on VAP prevention

Login

Agenda

9 - 12 March 2010

ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)

ISICEM

9 -11 June 2010

EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)

EACTA

12-15 June 2010

ESA European Society of Anaesthesiology - Helsinki (Finland)

ESA

18-22 September 2010

ERS European Respiratory Society - Barcellona (Spain)

ERS

9 -13 October 2010

ESICM European Society of Intensive Care Medicine - Barcellona (Spain)

ESICM

> International events

> Local events

Etiology

THE PATHOGEN OF VAP DOES NOT INFLUENCE THE MORTALITY RATE OF SURGICAL INTENSIVE CARE UNIT PATIENTS
RETROSPECTIVE ANALYSIS OF THE RISK FACTORS AND PATHOGENS ASSOCIATED WITH EARLY-ONSET-VAP IN SURGICAL
CAN ROUTINE SURVEILLANCE SAMPLES FROM TRACHEAL ASPIRATE PREDICT BACTERIAL FLORA IN CASES OF VAP?
MRSA AS A CAUSE OF LUNG INFECTION INCLUDING AIRWAY INFECTION,COMMUNITY-ACQUIRED PNEUMONIA AND HOSPIT
PLASMA CC16 LEVELS ARE ASSOCIATED WITH DEVELOPMENT OF ALI/ARDS IN PATIENTS WITH VAP: A RETROSPECTIVE
PROTEIN C DEPLATION EARLY AFTER TRAUMA INCREASES THE RISK OF VAP
DECREASE OF CD4-LYMPHOCYTES AND APOPTOSIS OF CD14-MONOCYTES ARE CHARACTERISTIC ALTERATIONS IN SEPSIS
BILE ACID ASPIRATION IN SUSPECTED VAP
MATRIX METALLOPROTEASES IN BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH TYPE III PSEUDOMONAS AERUGI
ACTIVE CYTOMEGALOVIRUS INFECTION IS COMMON IN MECHANICALLY VENTILATED MEDICAL INTENSIVE CARE UNIT PA
PNEUMONIA DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS:CLINICAL FEATURES, DIAGNOSIS AND MANAGE
CONDIDA ALBICANS IMPAIRS MACROPHAGE FUNCTION AND FACILITATES PSEUDOMONAS AERUGINOSA PNEUMONIA IN RAT
PATTERN AND DENSITY OF EARLY TRACHEAL COLONIZATION IN INTENSIVE CARE UNIT PATIENTS
VENTILATOR ASSOCIATED TRACHEOBRONCHITIS:THE IMPACT OF TARGETED ANTIBIOTIC THERAPY ON PATIENT OUTCOME
CLINICAL SIGNIFICANCE OF A POSITIVE SEROLOGY FOR MIMIVIRUS IN PATIENTS PRESENTING A SUSPICION OF VAP
DETERMINANTS AND IMPACT OF MULTIDRUG ANTIBIOTIC RESISTANCE IN PATHOGENS CAUSING VENTILATOR-ASSOCIATE
PREDICTING PATHOGENS CAUSING VENTILATOR-ASSOCIATED PNEUMONIA USING A BAYESIAN NETWORK MODEL
COLISTIN AND TIGECYCLINE SUSCEPTIBILITY AMONG MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII ISOLATED
IMPACT OF METHICILLIN RESISTANCE ON MORTALITY IN STAPHYLOCOCCUS AUREUS VAP: A SYSTEMATIC REVIEW
THE CLINICAL SIGNIFICANCE OF CANDIDA COLONIZATION OF RESPIRATORY TRACT SECRETIONS IN CRITICALLY ILL
VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY MULTIDRUG-RESISTANT ORGANISMS
VAP: IMPACT OF ORGANISM ON CLINICAL RESOLUTION AND MEDICAL RESOURCES UTILIZATION
VAP DUE TO COLISTIN SUSCEPTIBLE-ONLY MICROORGANISMS
MICROBIOLOGY OF VAP COMPARED WITH THAT OF HOSPITAL-ACQUIRED PNEUMONIA
EMERGENCE OF STAPHYLOCOCCAL CASSETTE CHROMOSOME MEC TYPE IV METHICILLIN-RESIST STAPH AUREUS IN VAP

<< Start < Prev 1 2 Next > End >>
Results 1 - 25 of 26

Cost ( 13 items )
Prevention ( 101 items )
Treatment ( 67 items )
Diagnosis ( 38 items )
Pathophysiology ( 8 items )
Epidemiology: Risk and prognosis factors ( 38 items )
EPIDEMIOLOGY

[ Back ]

Members

Select and watch
from the following webinars

Partner

VAPAWAY is proudly supported by Covidien.